Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

ClinicalTrials.gov ID: NCT01815840

Public ClinicalTrials.gov record NCT01815840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blinded, Regimen-controlled, Phase II, Multicenter Study to Assess the Efficacy and Safety of Two Different Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas

Study identification

NCT ID
NCT01815840
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
229 participants

Conditions and interventions

Interventions

  • Vismodegib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 29, 2013
Primary completion
Aug 26, 2015
Completion
Aug 30, 2016
Last update posted
Sep 27, 2017

2013 – 2016

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Dermatology Research Associate Los Angeles California 90045
Stanford University Palo Alto California 94305
Skin Surgery Med Group, Inc San Diego California 92117
California Pacific Medical Center Research Institute Santa Rosa California 95403
Advanced Derm & Cosmetic Surg Ormond Beach Florida 32174
Skin and Cancer Associates and the Center for Cosmetic Enhancement Plantation Florida 33324
Emory University Clinic Atlanta Georgia 30322
Laser & Skin Surgery Center of Indiana Carmel Indiana 46032
Beverly Hospital;Oncology Center Pharmacy Beverly Massachusetts 01915
Saint Louis University School of Medicine; Department of Dermatology St Louis Missouri 63104
Washington University School of Medicine St Louis Missouri 63110
Long Island Skin Cancer and Dermatologic Surgery Smithtown New York 11787
Mariwalla Dermatology West Islip New York 11795
The Skin Surgery Center Winston-Salem North Carolina 27106
Ohio State University Columbus Ohio 43210
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Dermatology and Laser Center of Charleston PA Charleston South Carolina 29414

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01815840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01815840 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →